Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Looks like it works
A 2021 systematic review noted inconsistent bioavailability data and called for more rigorous clinical trials
The cysteine modification is expected to trigger a conformational change of the Keap1 homodimer, which could dissociate the weak binding site, the DLG motif (latch), from the Keap1 DC domain, while the strong binding site, the ETGE motif (hinge), remains attached to the other Keap1 DC domain
What makes Epitalon interesting is that it doesnt just tackle one element - it touches multiple levels of neuronal health: Neurotransmitter regulation Synaptic plasticity Oxidative DNA protection Stem cell priming toward neurogenesis While human clinical data is still in its infancy, these cellular and animal results point to real potential for Epitalon in cognitive longevity strategies, neurodegenerative disease prevention, or even post-injury neural recovery
US$ 25.48
US$ 23.80
US$ 28.56
US$ 27.51
